Overview
Adam Coutts practices practicing medicine in Cambridge, United Kingdom.
His clinical expertise encompasses Chiari Malformation, Pseudotumor Cerebri Syndrome, and Chiari Malformation Type 2.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Adam P. Coutts
Is Adam P. Coutts a top-rated expert for Chiari Malformation?
MediFind is an objective health platform that identifies experts based on real-world data. Adam P. Coutts is classified as an Experienced expert for Chiari Malformation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Adam P. Coutts participate in research or clinical trials?
Yes. Adam P. Coutts has published 31 articles and abstracts on conditions like Chiari Malformation. You can view a list of Adam P. Coutts's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chiari MalformationMr. Coutts isExperienced. Learn about Chiari Malformation.
- Chiari Malformation Type 2Mr. Coutts isExperienced. Learn about Chiari Malformation Type 2.
- Pseudotumor Cerebri SyndromeMr. Coutts isExperienced. Learn about Pseudotumor Cerebri Syndrome.